Literature DB >> 6345991

Comparison of peripheral glucose uptake after oral glucose loading and a mixed meal.

R A Jackson, P M Blix, J A Matthews, L M Morgan, A H Rubenstein, J D Nabarro.   

Abstract

Forearm glucose uptake (FGU) and other metabolic responses were studied in six normal men for three hours after a 75-g oral glucose load and a mixed meal containing 75 g carbohydrate. After the meal the rise in arterial glucose levels was considerably less than that following the oral glucose load but the overall insulin responses from 0 to 180 minutes were not statistically different. Although the initial rise in FGU was more gradual after the meal, the subsequent elevation was more sustained and, at the termination of the study, exceeded significantly that seen after the oral glucose load. The rise in GIP levels during the first hour was similar after the meal and the oral glucose load, but thereafter concentrations following the oral glucose load fell while those after the meal continued to rise. When the incremental area (delta) is used as the index of response, the results show that while the glucose response (delta G) after the meal (19.1 +/- 5.3 units) was only 26% of that after oral glucose loading (72.7 +/- 7.0 units), the corresponding increase in FGU (delta FGU) reached 62% (55.0 +/- 12.8 units after the meal, 89.2 +/- 20.0 units after the oral glucose load). Thus, the increase in peripheral glucose uptake relative to the glycemic response (delta FGU/delta G) was significantly greater after the meal than following the oral glucose load alone (P less than 0.05). In conclusion, relative to the rise in arterial glucose levels, peripheral glucose uptake is greater after a meal than after glucose loading with an equivalent carbohydrate challenge. Furthermore, the present data support previous studies emphasizing the failure of GIP alone to explain the entero insular axis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345991     DOI: 10.1016/0026-0495(83)90128-2

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

1.  Intestinal handling of a glucose gavage by the rat.

Authors:  J A Fernández-López; J Casado; J M Argilés; M Alemany
Journal:  Mol Cell Biochem       Date:  1992-07-06       Impact factor: 3.396

2.  Glucose-dependent insulinotropic polypeptide directly induces glucose transport in rat skeletal muscle.

Authors:  Laelie A Snook; Emery M Nelson; David J Dyck; David C Wright; Graham P Holloway
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-03       Impact factor: 3.619

Review 3.  The physiological basis of insulin treatment--clinical aspects.

Authors:  W K Waldhäusl
Journal:  Diabetologia       Date:  1986-12       Impact factor: 10.122

4.  Effect of the enteroinsular axis on both the A- and B-cell response to arginine after oral glucose in man.

Authors:  I Shimizu; M Hirota; C Ohboshi; A Mizuno; K Shima
Journal:  Diabetologia       Date:  1987-11       Impact factor: 10.122

Review 5.  Clinical pharmacokinetics and pharmacodynamics of vildagliptin.

Authors:  Yan-Ling He
Journal:  Clin Pharmacokinet       Date:  2012-03-01       Impact factor: 6.447

6.  Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.

Authors:  D Kelley; A Mitrakou; H Marsh; F Schwenk; J Benn; G Sonnenberg; M Arcangeli; T Aoki; J Sorensen; M Berger
Journal:  J Clin Invest       Date:  1988-05       Impact factor: 14.808

7.  Ubiquitination is involved in glucose-mediated downregulation of GIP receptors in islets.

Authors:  Jie Zhou; Mauren F A Livak; Michel Bernier; Denis C Muller; Olga D Carlson; Dariush Elahi; Stuart Maudsley; Josephine M Egan
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-05-15       Impact factor: 4.310

8.  MG132 protects against renal dysfunction by regulating Akt-mediated inflammation in diabetic nephropathy.

Authors:  Wei Zeng; Wei Qi; Jiao Mu; Yi Wei; Li-Ling Yang; Qian Zhang; Qiong Wu; Jian-Ying Tang; Bing Feng
Journal:  Sci Rep       Date:  2019-02-14       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.